ERBB2 and breast cancer: Using a multivariate cox proportional hazards model adjusted for age, sex, race, and year of diagnosis, we found poorer OS in patients with HER2− breast cancers compared to patients with HER2+ breast cancers (HR: 1.15 [95% CI: 1.08–1.22], P < .001).